{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T12:59:11Z","timestamp":1772801951624,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.ijantimicag.2007.06.029","type":"journal-article","created":{"date-parts":[[2007,9,5]],"date-time":"2007-09-05T07:26:49Z","timestamp":1188977209000},"page":"415-421","source":"Crossref","is-referenced-by-count":27,"title":["Activity of moxifloxacin on biofilms produced in vitro by bacterial pathogens involved in acute exacerbations of chronic bronchitis"],"prefix":"10.1016","volume":"30","author":[{"given":"S.","family":"Roveta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"Schito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Marchese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.C.","family":"Schito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2007.06.029_bib1","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.284.5418.1318","article-title":"Bacterial biofilms: a common cause of persistent infections","volume":"284","author":"Costerton","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.ijantimicag.2007.06.029_bib2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1128\/CMR.15.2.167-193.2002","article-title":"Biofilms: survival mechanisms of clinically relevant microorganisms","volume":"15","author":"Donlan","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2007.06.029_bib3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1128\/CMR.15.2.155-166.2002","article-title":"Bacterial adhesion: seen any good biofilms lately","volume":"15","author":"Dunne","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2007.06.029_bib4","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1056\/NEJMcibr021776","article-title":"Biofilms, antimicrobial resistance, and airway infection","volume":"347","author":"Prince","year":"2002","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.ijantimicag.2007.06.029_bib5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.amjmed.2005.05.012","article-title":"Appropriate outpatient treatment of acute bacterial exacerbations of chronic bronchitis","volume":"118","author":"Martinez","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2007.06.029_bib6","series-title":"Manual of clinical microbiology","author":"Murray","year":"1999"},{"key":"10.1016\/j.ijantimicag.2007.06.029_bib7","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Sixteenth informational supplement. M100-S16. Wayne, PA: CLSI; 2006."},{"key":"10.1016\/j.ijantimicag.2007.06.029_bib8","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1136\/jcp.42.8.872","article-title":"New method for detecting slime production by coagulase-negative staphylococci","volume":"42","author":"Freeman","year":"1989","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ijantimicag.2007.06.029_bib9","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1128\/AEM.68.3.1196-1203.2002","article-title":"Functional genomics approach to identifying genes required for biofilm development by Streptococcus mutans","volume":"68","author":"Wen","year":"2002","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.ijantimicag.2007.06.029_bib10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1128\/IAI.73.1.219-225.2005","article-title":"Trigger factor in Streptococcus mutans is involved in stress tolerance, competence development, and biofilm formation","volume":"73","author":"Wen","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2007.06.029_bib11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0076-6879(01)36593-X","article-title":"In vitro methods to study biofilm formation","volume":"336","author":"Cramton","year":"2001","journal-title":"Methods Enzymol"},{"issue":"Suppl 2","key":"10.1016\/j.ijantimicag.2007.06.029_bib12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0924-8579(03)00232-2","article-title":"Effect of fosfomycin alone and in combination with N-acetylcysteine on E. coli biofilms","volume":"22","author":"Marchese","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2007.06.029_bib13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0140-6736(03)12245-3","article-title":"New ways to stop biofilm infections","volume":"361","author":"Stewart","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2007.06.029_bib14","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1586\/14787210.1.3.363","article-title":"Moxifloxacin (Avelox): a novel fluoroquinolone with a broad spectrum of activity","volume":"1","author":"Caeiro","year":"2003","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2007.06.029_bib15","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1128\/AAC.43.10.2345","article-title":"Penetration of moxifloxacin into peripheral compartments in humans","volume":"43","author":"Muller","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl B","key":"10.1016\/j.ijantimicag.2007.06.029_bib16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/jac\/43.suppl_2.83","article-title":"Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in man","volume":"43","author":"Stass","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2007.06.029_bib17","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1128\/AAC.43.6.1508","article-title":"Pharmacokinetics and inflammatory-fluid penetration of moxifloxacin following oral or intravenous administration","volume":"43","author":"Wise","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2007.06.029_bib18","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0149-2918(04)90170-1","article-title":"Safety profile of oral and intravenous moxifloxacin: cumulative data from clinical trials and postmarketing studies","volume":"26","author":"Ball","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.ijantimicag.2007.06.029_bib19","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/jac\/44.6.835","article-title":"Concentrations of moxifloxacin in serum and pulmonary compartments following a single 400mg oral dose in patients undergoing fibre-optic bronchoscopy","volume":"44","author":"Soman","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2007.06.029_bib20","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0009-9236(03)00201-7","article-title":"Population pharmacokinetics of moxifloxacin in plasma and bronchial secretions in patients with severe bronchopneumonia","volume":"74","author":"Simon","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2007.06.029_bib21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1128\/AAC.48.1.151-160.2004","article-title":"Biofilm formation by Stenotrophomonas maltophilia: modulation by quinolones, trimethoprim\u2013sulfamethoxazole, and ceftazidime","volume":"48","author":"Di Bonaventura","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2007.06.029_bib22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000077811","article-title":"Moxifloxacin and biofilm production by coagulase-negative staphylococci","volume":"50","author":"Perez-Giraldo","year":"2004","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2007.06.029_bib23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/jac\/dki198","article-title":"Telavancin: in vitro activity against staphylococci in a biofilm model","volume":"56","author":"Gander","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2007.06.029_bib24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/jac\/dkh479","article-title":"Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics","volume":"55","author":"Presterl","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2007.06.029_bib25","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1128\/AAC.01052-06","article-title":"In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates","volume":"53","author":"Frank","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2007.06.029_bib26","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.0303-6979.2004.00490.x","article-title":"Efficacy of antibiotics to strains of periodontopathogenic bacteria within a single species biofilm\u2014an in vitro study","volume":"31","author":"Eick","year":"2004","journal-title":"J Clin Periodontol"},{"key":"10.1016\/j.ijantimicag.2007.06.029_bib27","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ijantimicag.2005.12.003","article-title":"Treatment of implant-associated infections with moxifloxacin: an animal study","volume":"27","author":"Kalteis","year":"2006","journal-title":"Int J Antimicrob Agents"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857907003184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857907003184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T17:03:54Z","timestamp":1556816634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857907003184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0924857907003184"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2007.06.029","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}